Blog
0
Dato-DXd Extends PFS in HR+/HER2- Inoperable or Metastatic Breast Cancer
0

Dato-DXd (datopotamab deruxtecan) compared to chemotherapy showed improvements with progression-free survival (PFS, the time from randomization or ...

0
Tukysa Plus Kadcyla Improves PFS in Previously Treated HER2+ Metastatic Breast Cancer
0

The addition of Tukysa (tucatinib) to Kadcyla (ado-trastuzumab emtansine) improved progression-free survival compared with placebo plus Kadcyla.In patients ...

0
Winterizing Exercise With Cancer
0

I am not in perfect physical shape. I struggle to do a push up. I breathe darn hard when climbing hills (I blame 20 years of flatland living) and let’s not ...

0
No Racial Difference in Recurrence-Free Survival in HR+, HER2- Breast Cancer
0

The BluePrint (BP) and MammaPrint (MP) assays (procedures) determined that three-year recurrence-free survival (RFS; staying alive without cancer returning) ...

0
Keytruda Plus Chemo Improves Complete Response Rate in Breast Cancer
0

Incorporating Keytruda (pembrolizumab) with neoadjuvant chemotherapy, followed by Keytruda in combination with endocrine therapy, demonstrated enhanced ...

0
Phase 2 Evaluating BDC-1001 Plus Perjeta in HER2-Positive Breast Cancer
0

The antitumor activity of immune-stimulating antibody conjugate (ISAC) BDC-1001, when combined with Perjeta (pertuzumab), in various HER2 tumor-expressing ...

0
Truqap Plus Faslodex Boosts Breast Cancer Outcomes, Quality of Life
0

Health-related quality of life (HRQOL), which measures the impact of health conditions on patients’ functioning, was maintained for longer in patients with ...

0
Sentinel Lymph Nodes May Be Detected With AI in Breast Cancer
0

The trial found a significantly lower risk of immunohistochemistry use to detect sentinel lymph node metastases when AI was used.Artificial intelligence ...

0
A Cancer Survivor’s Ghosts of Holidays Past
0

The singing voice of the Christmas song is the voice of my brother John Henry, who died almost 50 years ago of Disseminated Hodgkin’s Lymphoma. I am ...

0
Kisqali Plus Endocrine Therapy Improves Survival in HR+/HER2– Breast Cancer
0

Kisqali plus endocrine therapy improved progression-free and overall survival in certain patients with breast cancer.Patients with hormone receptor ...

0
FDA Accepts Priority Review for Opdivo Plus Chemo in Bladder Cancer Subtype
0

The U.S. Food and Drug Administration (FDA) has accepted a priority review for the supplemental Biologics License Application of Opdivo (nivolumab) plus ...

0
Beans Improve Gut Health of Colorectal Cancer Survivors
0

Colorectal cancer survivors who incorporated beans into their diet experienced gut health improvements, according to recent research.Participants who added ...

CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart